Insights from Marketing Mix Studies in Pharma

This report presents insights derived from over 140 marketing mix studies conducted within the pharmaceutical industry, focusing on the evolution of sales and marketing strategies from January 2018 to December 2022. It outlines the significant shift towards digital marketing channels, emphasizing the growing importance of online presence, social media engagement, email promotions, and content marketing. The analysis highlights trends in spending patterns, revealing a marked increase in digital media investment, which rose from 6% to 22% of overall multichannel spend over the five-year period. Additionally, the report discusses the effectiveness of various digital channels, noting improvements in return on investment (ROI) for growth and mature products. It details how digital channels, including telemedicine and e-detailing, have transformed interactions between healthcare professionals and pharmaceutical sales representatives. The findings underscore the necessity for pharma companies to adapt to changing consumer behaviors and technological advancements to enhance engagement and optimize marketing strategies.